FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1573030605> ?p ?o ?g. }

• W1573030605 endingPage "80" @default.
• W1573030605 startingPage "373" @default.
• W1573030605 abstract "The drugs available in the Portuguese market, for the treatment of osteoporosis, have different mechanisms of action, efficacy, indications, safety profile, and cost, which may influence prescription and acquisition by patients.To describe the use of drugs for osteoporosis treatment (estimated by sales), between 1998 and 2004, and the geographical variation in the drug utilization, in 2004.Data was obtained from IMS Health for the sales of drugs used in the ambulatory treatment of osteoporosis, in the whole country, from 1998 to 2004, and by region, in 2004. For each group (bisphosphonates, raloxifene, calcitonins, Hormone replacement therapy (HRT) and calcium and vitamin D), we computed the sum of the amount of packages and the value of the sales in each year, regardless of the strength or the package size. For bisphosphonates, raloxifene and calcitonins, we computed the DDD (Defined Daily Dose) sold in Portugal. All consumption data are presented by women aged 45 to 74 years. National data was used to describe the trends in sales, from 1998 to 2004, and regional data was used to map the 2004 consumptions.The expenses with drugs used in osteoporosis increased 60% from 1998 to 2004. The bisphosphonates sales increased more than five times, and in 2004 this group was responsible for 60% of the national market of drugs for osteoporosis treatment. Raloxifene represented approximately 10% of the sales in 2004. The consumption of calcitonins decreased nearly 70% in the observation period. The use of HRT increased 30% to 40% until 2001/2002, and decreased just about the same from there on. Geographical differences were observed in the sales of osteoporosis drugs in 2004, the amplitude of variation ranging from two (bisphosphonates, calcium and vitamin D, HRT) to three times (raloxifene, calcitonins) across regions. The lowest consumptions were observed in Beja and Bragança, and the highest in Aveiro. Raloxifene is used mainly in the Northwest of the country, and HRT in the sea side regions.In Portugal, the trends in the consumption of drugs used for osteoporosis treatment, as well as the relative weight of each pharmacological group, follow a similar pattern to the observed in other countries. The differences in consumption across the years and regions may reflect a variation in the frequency of disease or in the proportion of subjects being treated, but the magnitude of the variation suggests that there are unmet needs in diagnosis and treatment of osteoporosis in our country, and that social and economic factors may contribute to the regional differences observed." @default.
• W1573030605 created "2016-06-24" @default.
• W1573030605 creator A5006350891 @default.
• W1573030605 creator A5006965022 @default.
• W1573030605 creator A5043611020 @default.
• W1573030605 creator A5086747949 @default.
• W1573030605 date "2007-03-08" @default.
• W1573030605 modified "2023-09-24" @default.
• W1573030605 title "Tratamento da osteoporose em Portugal: tendência e variação geográfica." @default.
• W1573030605 doi "https://doi.org/10.20344/amp.978" @default.
• W1573030605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17376323" @default.
• W1573030605 hasPublicationYear "2007" @default.
• W1573030605 type Work @default.
• W1573030605 sameAs 1573030605 @default.
• W1573030605 citedByCount "11" @default.
• W1573030605 countsByYear W15730306052013 @default.
• W1573030605 countsByYear W15730306052016 @default.
• W1573030605 countsByYear W15730306052018 @default.
• W1573030605 crossrefType "journal-article" @default.
• W1573030605 hasAuthorship W1573030605A5006350891 @default.
• W1573030605 hasAuthorship W1573030605A5006965022 @default.
• W1573030605 hasAuthorship W1573030605A5043611020 @default.
• W1573030605 hasAuthorship W1573030605A5086747949 @default.
• W1573030605 hasBestOaLocation W15730306051 @default.
• W1573030605 hasConcept C121608353 @default.
• W1573030605 hasConcept C126322002 @default.
• W1573030605 hasConcept C138885662 @default.
• W1573030605 hasConcept C2426938 @default.
• W1573030605 hasConcept C2776541429 @default.
• W1573030605 hasConcept C2777176818 @default.
• W1573030605 hasConcept C2779279991 @default.
• W1573030605 hasConcept C2779889926 @default.
• W1573030605 hasConcept C2780159708 @default.
• W1573030605 hasConcept C35219183 @default.
• W1573030605 hasConcept C35785553 @default.
• W1573030605 hasConcept C41895202 @default.
• W1573030605 hasConcept C530470458 @default.
• W1573030605 hasConcept C71924100 @default.
• W1573030605 hasConcept C83559648 @default.
• W1573030605 hasConcept C98274493 @default.
• W1573030605 hasConcept C99454951 @default.
• W1573030605 hasConceptScore W1573030605C121608353 @default.
• W1573030605 hasConceptScore W1573030605C126322002 @default.
• W1573030605 hasConceptScore W1573030605C138885662 @default.
• W1573030605 hasConceptScore W1573030605C2426938 @default.
• W1573030605 hasConceptScore W1573030605C2776541429 @default.
• W1573030605 hasConceptScore W1573030605C2777176818 @default.
• W1573030605 hasConceptScore W1573030605C2779279991 @default.
• W1573030605 hasConceptScore W1573030605C2779889926 @default.
• W1573030605 hasConceptScore W1573030605C2780159708 @default.
• W1573030605 hasConceptScore W1573030605C35219183 @default.
• W1573030605 hasConceptScore W1573030605C35785553 @default.
• W1573030605 hasConceptScore W1573030605C41895202 @default.
• W1573030605 hasConceptScore W1573030605C530470458 @default.
• W1573030605 hasConceptScore W1573030605C71924100 @default.
• W1573030605 hasConceptScore W1573030605C83559648 @default.
• W1573030605 hasConceptScore W1573030605C98274493 @default.
• W1573030605 hasConceptScore W1573030605C99454951 @default.
• W1573030605 hasIssue "5" @default.
• W1573030605 hasLocation W15730306051 @default.
• W1573030605 hasLocation W15730306052 @default.
• W1573030605 hasLocation W15730306053 @default.
• W1573030605 hasOpenAccess W1573030605 @default.
• W1573030605 hasPrimaryLocation W15730306051 @default.
• W1573030605 hasRelatedWork W1972792859 @default.
• W1573030605 hasRelatedWork W1996155847 @default.
• W1573030605 hasRelatedWork W2022931070 @default.
• W1573030605 hasRelatedWork W2092885283 @default.
• W1573030605 hasRelatedWork W2113165663 @default.
• W1573030605 hasRelatedWork W2134062550 @default.
• W1573030605 hasRelatedWork W2411680412 @default.
• W1573030605 hasRelatedWork W2993506842 @default.
• W1573030605 hasRelatedWork W2995839444 @default.
• W1573030605 hasRelatedWork W4292258670 @default.
• W1573030605 hasVolume "19" @default.
• W1573030605 isParatext "false" @default.
• W1573030605 isRetracted "false" @default.
• W1573030605 magId "1573030605" @default.
• W1573030605 workType "article" @default.